6-38256473-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001099272.2(BTBD9):c.1498G>A(p.Val500Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000389 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001099272.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTBD9 | NM_001099272.2 | c.1498G>A | p.Val500Ile | missense_variant | 9/11 | ENST00000481247.6 | NP_001092742.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BTBD9 | ENST00000481247.6 | c.1498G>A | p.Val500Ile | missense_variant | 9/11 | 5 | NM_001099272.2 | ENSP00000418751.1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152186Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000229 AC: 57AN: 249300Hom.: 0 AF XY: 0.000281 AC XY: 38AN XY: 135240
GnomAD4 exome AF: 0.000412 AC: 602AN: 1461712Hom.: 0 Cov.: 30 AF XY: 0.000391 AC XY: 284AN XY: 727164
GnomAD4 genome AF: 0.000171 AC: 26AN: 152304Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 13AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2023 | The c.1498G>A (p.V500I) alteration is located in exon 10 (coding exon 8) of the BTBD9 gene. This alteration results from a G to A substitution at nucleotide position 1498, causing the valine (V) at amino acid position 500 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at